Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Diabetes

  Free Subscription


Articles published in Ophthalmology

Retrieve available abstracts of 67 articles:
HTML format



Single Articles


    June 2021
  1. KANCLERZ P, Hecht I, Tuuminen R
    Re: Lois et al.: Evaluation of a new model of care for people with complications of diabetic retinopathy: The EMERALD Study (Ophthalmology. 2021;128:561-573).
    Ophthalmology. 2021 Jun 24. pii: S0161-6420(21)00371.
    PubMed    


  2. ANTAKI F, Nehme A, Najem K
    Reversible Homonymous Hemianopia in a Newly Diagnosed Diabetic Man.
    Ophthalmology. 2021;128:826.
    PubMed    


    April 2021
  3. TEO ZL, Tham YC, Yan Yu MC, Chee ML, et al
    Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis.
    Ophthalmology. 2021 Apr 30. pii: S0161-6420(21)00321.
    PubMed     Abstract available


  4. RAVILLA T
    A Holistic Perspective in Caring for People with Diabetic Retinopathy.
    Ophthalmology. 2021;128:574-575.
    PubMed    


    March 2021
  5. MALHOTRA NA, Greenlee TE, Iyer AI, Conti TF, et al
    Racial, Ethnic, and Insurance-Based Disparities Upon Initiation of Anti-VEGF Therapy for Diabetic Macular Edema in the United States.
    Ophthalmology. 2021 Mar 11. pii: S0161-6420(21)00196.
    PubMed     Abstract available


    February 2021
  6. CUI Y, Zhu Y, Lu ES, Le R, et al
    Widefield Swept-source OCT Angiography Metrics Associated with the Development of Diabetic Vitreous Hemorrhage A Prospective Study.
    Ophthalmology. 2021 Feb 26. pii: S0161-6420(21)00154.
    PubMed     Abstract available


    December 2020
  7. MODJTAHEDI BS, Wu J, Luong TQ, Gandhi NK, et al
    Severity of diabetic retinopathy and the risk of future cerebrovascular disease, cardiovascular disease, and all-cause mortality.
    Ophthalmology. 2020 Dec 24. pii: S0161-6420(20)31195.
    PubMed     Abstract available


    November 2020
  8. SUN JK, Aiello LP, Abramoff MD, Antonetti DA, et al
    Updating the Staging System for Diabetic Retinal Disease.
    Ophthalmology. 2020 Nov 17. pii: S0161-6420(20)31005.
    PubMed    


    October 2020
  9. LOIS N, Cook JA, Wang A, Aldington S, et al
    Evaluation of a new model of care for people with complications of diabetic retinopathy: The EMERALD Study.
    Ophthalmology. 2020 Oct 29. pii: S0161-6420(20)31032.
    PubMed     Abstract available


    September 2020
  10. HAINSWORTH DP, Gao X, Bebu I, Das A, et al
    Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: the DCCT/EDIC Study.
    Ophthalmology. 2020 Sep 14. pii: S0161-6420(20)30896.
    PubMed     Abstract available


    July 2020
  11. CHEN EM, Chen D, Chilakamarri P, Lopez R, et al
    Economic Challenges of Artificial Intelligence Adoption for Diabetic Retinopathy.
    Ophthalmology. 2020 Jul 24. pii: S0161-6420(20)30733.
    PubMed     Abstract available


  12. CHAUM E
    Detection of Lipemia Retinalis During Telemedical Diabetic Retinopathy Screening.
    Ophthalmology. 2020;127:900.
    PubMed    


  13. BINDMAN AB
    Expanding Coverage Does Not Guarantee a Benefit.
    Ophthalmology. 2020;127:929-930.
    PubMed    


    May 2020
  14. WINTERGERST MWM, Mishra DK, Hartmann L, Shah P, et al
    Diabetic retinopathy screening using smartphone-based fundus imaging in India.
    Ophthalmology. 2020 May 14. pii: S0161-6420(20)30463.
    PubMed     Abstract available


  15. BORRELLI E, Sacconi R, Querques G
    Re: Couturier et al.: Widefield OCT-angiography and fluorescein angiography assessments of nonperfusion in diabetic retinopathy and edema treated with anti-vascular endothelial growth factor (Ophthalmology. 2019;126:1685-1694).
    Ophthalmology. 2020;127:e32-e34.
    PubMed    


  16. COUTURIER A, Lavia C, Gaudric A, Tadayoni R, et al
    Reply.
    Ophthalmology. 2020;127:e34-e35.
    PubMed    


    April 2020

  17. Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs - An Extension of the Modified Airlie House Classification: ETDRS Report Number 10.
    Ophthalmology. 2020;127.
    PubMed     Abstract available


  18. SADDA SR
    Assessing the Severity of Diabetic Retinopathy: Early Treatment Diabetic Retinopathy Study Report Number 10.
    Ophthalmology. 2020;127.
    PubMed    


  19. MAA AY, McCord S, Lu X, Janjua R, et al
    The Impact of OCT on Diagnostic Accuracy of the Technology-Based Eye Care Services Protocol: Part II of the Technology-Based Eye Care Services Compare Trial.
    Ophthalmology. 2020;127:544-549.
    PubMed     Abstract available


  20. BRANDT JD, Beiser JA, Kass MA, Gordon MO, et al
    Central Corneal Thickness in the Ocular Hypertension Treatment Study (OHTS).
    Ophthalmology. 2020;127.
    PubMed     Abstract available


    March 2020
  21. GLASSMAN AR, Wells JA 3rd, Josic K, Maguire MG, et al
    Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study).
    Ophthalmology. 2020 Mar 29. pii: S0161-6420(20)30304.
    PubMed     Abstract available


    December 2019
  22. TSUBOI K, Ishida Y, Kamei M
    Congenital Retinal Macrovessel Strays into Deep Capillary Plexus.
    Ophthalmology. 2019;126:1658.
    PubMed    


    November 2019
  23. BHANDARI S, Nguyen V, Fraser-Bell S, Mehta H, et al
    Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry.
    Ophthalmology. 2019 Nov 26. pii: S0161-6420(19)32299.
    PubMed     Abstract available


    October 2019
  24. CANTRELL RA, Lum F, Chia Y, Morse LS, et al
    Treatment Patterns for Diabetic Macular Edema: An Intelligent Research in Sight (IRIS(R)) Registry Analysis.
    Ophthalmology. 2019 Oct 23. pii: S0161-6420(19)32176.
    PubMed    


  25. ROSENBLATT A, Udaondo P, Cunha-Vaz J, Sivaprasad S, et al
    A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study.
    Ophthalmology. 2019 Oct 10. pii: S0161-6420(19)32112.
    PubMed     Abstract available


    September 2019
  26. FLAXEL CJ, Adelman RA, Bailey ST, Fawzi A, et al
    Diabetic Retinopathy Preferred Practice Pattern(R).
    Ophthalmology. 2019 Sep 25. pii: S0161-6420(19)32092.
    PubMed    


  27. CHEN EM, Armstrong GW, Cox JT, Wu DM, et al
    Association of the Affordable Care Act Medicaid Expansion with Dilated Eye Examinations among the United States Population with Diabetes.
    Ophthalmology. 2019 Sep 17. pii: S0161-6420(19)32056.
    PubMed     Abstract available


  28. JUNCAL VR, Paracha Q, Bamakrid M, Francisconi CLM, et al
    Ranibizumab and Aflibercept Levels in Breast Milk after Intravitreal Injection.
    Ophthalmology. 2019 Sep 12. pii: S0161-6420(19)31953.
    PubMed    


  29. MANDVIWALA MM, Weinberg DV, Hwang ES
    Edema within Epiretinal Proliferation in a Diabetic Patient.
    Ophthalmology. 2019;126:1272.
    PubMed    


    August 2019
  30. GONZALEZ VH, Wang PW, Ruiz CQ
    Panretinal Photocoagulation for Diabetic Retinopathy in the RIDE and RISE Trials: Not "1 and Done".
    Ophthalmology. 2019 Aug 21. pii: S0161-6420(19)31932.
    PubMed     Abstract available


    June 2019
  31. SUN Z, Tang F, Wong R, Lok J, et al
    OCT Angiography Metrics Predict Progression of Diabetic Retinopathy and Development of Diabetic Macular Edema: A Prospective Study.
    Ophthalmology. 2019 Jun 26. pii: S0161-6420(19)30608.
    PubMed     Abstract available


  32. COUTURIER A, Rey PA, Erginay A, Lavia C, et al
    Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor.
    Ophthalmology. 2019 Jun 26. pii: S0161-6420(19)30304.
    PubMed     Abstract available


  33. EPPLEY SE, Mansberger SL, Ramanathan S, Lowry EA, et al
    Characteristics Associated with Adherence to Annual Dilated Eye Examinations among US Patients with Diagnosed Diabetes.
    Ophthalmology. 2019 Jun 15. pii: S0161-6420(19)30130.
    PubMed     Abstract available


  34. EHLERS JP, Jiang AC, Boss JD, Hu M, et al
    Quantitative Ultra-Widefield Angiography and Diabetic Retinopathy Severity: An Assessment of Panretinal Leakage Index, Ischemic Index and Microaneurysm Count.
    Ophthalmology. 2019 Jun 8. pii: S0161-6420(19)30413.
    PubMed     Abstract available


    May 2019
  35. FRANK RN
    Anti-Vascular Endothelial Growth Factor Injections for Diabetic Retinopathy: Continued Progress, More Questions.
    Ophthalmology. 2019;126:721-722.
    PubMed    


    April 2019
  36. WYKOFF CC, Shah C, Dhoot D, Coleman HR, et al
    Longitudinal Retinal Perfusion Status in Eyes with Diabetic Macular Edema Receiving Intravitreal Aflibercept or Laser in VISTA study.
    Ophthalmology. 2019 Apr 1. pii: S0161-6420(18)33320.
    PubMed     Abstract available


  37. DUNCAN JL
    Ciliary Neurotrophic Factor Treatment Improves Retinal Structure and Function in Macular Telangiectasia Type 2.
    Ophthalmology. 2019;126:550-551.
    PubMed    


    March 2019
  38. SAHNI J, Patel SS, Dugel PU, Khanani AM, et al
    Simultaneous Inhibition of Angiopoietin-2 and VEGF-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial.
    Ophthalmology. 2019 Mar 21. pii: S0161-6420(18)33358.
    PubMed     Abstract available


  39. SCHACHAT AP
    If There Is Loss to Follow Up, Poor Outcomes May Be More Common after Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Retinopathy.
    Ophthalmology. 2019;126:414.
    PubMed    


    November 2018
  40. SAYRES R, Taly A, Rahimy E, Blumer K, et al
    Using a deep learning algorithm and integrated gradients explanation to assist grading for diabetic retinopathy.
    Ophthalmology. 2018 Nov 28. pii: S0161-6420(18)31575.
    PubMed     Abstract available


  41. SUN JK, Wang PW, Taylor S, Haskova Z, et al
    Durability of Diabetic Retinopathy Improvement with As-Needed Ranibizumab: Open-label Extension of RIDE and RISE Studies.
    Ophthalmology. 2018 Nov 9. pii: S0161-6420(18)30817.
    PubMed     Abstract available


  42. DU S, Chen S
    Re: Jampol et al.: Plasma vascular endothelial growth factor concentrations after intravitreous anti-vascular endothelial growth factor therapy for diabetic macular edema (Ophthalmology. 2018;7:1054-1063).
    Ophthalmology. 2018;125:e81-e82.
    PubMed    


    October 2018
  43. MALONEY MH, Schilz SR, Herrin J, Sangaralingham LR, et al
    Risk of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice.
    Ophthalmology. 2018 Oct 4. pii: S0161-6420(18)30063.
    PubMed     Abstract available


    September 2018
  44. SRIVASTAV K, Baskaran P
    Re: Zur et al.: OCT biomarkers as functional outcome predictors in diabetic macular edema treated with dexamethasone implant (Ophthalmology. 2018;125:267-275).
    Ophthalmology. 2018;125:e61.
    PubMed    


    August 2018
  45. NAKASHIMA H, Iwama Y, Tanioka K, Emi K, et al
    Paracentral Acute Middle Maculopathy following Vitrectomy for Proliferative Diabetic Retinopathy: Incidence, Risk Factors, and Clinical Characteristics.
    Ophthalmology. 2018 Aug 17. pii: S0161-6420(18)30905.
    PubMed     Abstract available


  46. SUN JK, Glassman AR, Beaulieu WT, Stockdale CR, et al
    Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy.
    Ophthalmology. 2018 Aug 7. pii: S0161-6420(18)31489.
    PubMed     Abstract available


  47. OBEID A, Su D, Patel SN, Uhr JH, et al
    Outcomes of Eyes Lost to Follow-Up with Proliferative Diabetic Retinopathy that received Panretinal Photocoagulation vs Intravitreal Anti-Vascular Endothelial Growth Factor.
    Ophthalmology. 2018 Aug 2. pii: S0161-6420(18)31079.
    PubMed     Abstract available


    July 2018
  48. BRESSLER SB, Beaulieu WT, Glassman AR, Gross JG, et al
    Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes.
    Ophthalmology. 2018 Jul 3. pii: S0161-6420(18)30577.
    PubMed     Abstract available


    May 2018
  49. KLEIN R, Lee KE, Danforth L, Tsai MY, et al
    The Relationship of Retinal Vessel Geometric Characteristics to the Incidence and Progression of Diabetic Retinopathy.
    Ophthalmology. 2018 May 17. pii: S0161-6420(18)30530.
    PubMed     Abstract available


  50. WONG TY, Sun J, Kawasaki R, Ruamviboonsuk P, et al
    Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings.
    Ophthalmology. 2018 May 15. pii: S0161-6420(17)33523.
    PubMed     Abstract available


  51. REDDY RK, Pieramici DJ, Gune S, Ghanekar A, et al
    Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE.
    Ophthalmology. 2018 May 8. pii: S0161-6420(17)33607.
    PubMed     Abstract available


  52. PAYNE JF, Clark WL, Bruce BB, Wykoff CC, et al
    Retinopathy Regression with Treat and Extend Ranibizumab for Diabetic Macular Edema.
    Ophthalmology. 2018 May 2. pii: S0161-6420(18)30678.
    PubMed    


    March 2018
  53. LIN J, Chang JS, Yannuzzi NA, Smiddy WE, et al
    Cost Evaluation of Early Vitrectomy versus Panretinal Photocoagulation and Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.
    Ophthalmology. 2018 Mar 29. pii: S0161-6420(18)30040.
    PubMed     Abstract available


  54. OBEID A, Gao X, Ali FS, Talcott KE, et al
    Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy after Panretinal Photocoagulation or Intravitreal Anti-VEGF Injections.
    Ophthalmology. 2018 Mar 29. pii: S0161-6420(17)33569.
    PubMed     Abstract available


  55. YANNUZZI NA, Sridhar J, Chang JS, Lin J, et al
    Cost Evaluation of Laser versus Intravitreal Aflibercept for Proliferative Diabetic Retinopathy.
    Ophthalmology. 2018 Mar 20. pii: S0161-6420(18)30299.
    PubMed    


  56. GUPTA P, Liang Gan AT, Kidd Man RE, Fenwick EK, et al
    Impact of Incidence and Progression of Diabetic Retinopathy on Vision-Specific Functioning.
    Ophthalmology. 2018 Mar 20. pii: S0161-6420(17)32967.
    PubMed     Abstract available


  57. JAMPOL LM, Glassman AR, Liu D, Aiello LP, et al
    Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.
    Ophthalmology. 2018 Mar 7. pii: S0161-6420(17)32232.
    PubMed     Abstract available


  58. KRAUSE J, Gulshan V, Rahimy E, Karth P, et al
    Grader Variability and the Importance of Reference Standards for Evaluating Machine Learning Models for Diabetic Retinopathy.
    Ophthalmology. 2018 Mar 2. pii: S0161-6420(17)32698.
    PubMed     Abstract available


    February 2018
  59. LIU L, Tham YC
    Re: Keel et al.: The prevalence of diabetic retinopathy in Australian adults with self-reported diabetes: The National Eye Health Survey (Ophthalmology. 2017;124:977-984).
    Ophthalmology. 2018;125:e13-e14.
    PubMed    


    January 2018
  60. FIGUEIRA J, Fletcher E, Massin P, Silva R, et al
    Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
    Ophthalmology. 2018 Jan 27. pii: S0161-6420(17)32188.
    PubMed     Abstract available


  61. BROWN DM, Ou WC, Wong TP, Kim RY, et al
    Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial.
    Ophthalmology. 2018 Jan 11. pii: S0161-6420(17)31641.
    PubMed     Abstract available


  62. GRZYBOWSKI A, Kanclerz P
    Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: result of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785).
    Ophthalmology. 2018;125:e8-e9.
    PubMed    


  63. JONNA G, Kim SJ
    Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785).
    Ophthalmology. 2018;125:e4.
    PubMed    


  64. MODJTAHEDI BS, Fong DS
    Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785).
    Ophthalmology. 2018;125:e10-e11.
    PubMed    


    December 2017
  65. TAN GS, Gan A, Sabanayagam C, Tham YC, et al
    Ethnic Differences in the Prevalence and Risk Factors of Diabetic Retinopathy: The Singapore Epidemiology of Eye Diseases Study.
    Ophthalmology. 2017 Dec 4. pii: S0161-6420(17)31893.
    PubMed     Abstract available


  66. THOMAS M, Rao RC, Johnson MW, Paulus YM, et al
    Re: Bressler et al.: Factors associated with worsening proliferative diabetic retinopathy in eyes treated with panretinal photocoagulation or ranibizumab (Ophthalmology. 2017;124:431-439).
    Ophthalmology. 2017;124:e87-e88.
    PubMed    


    September 2017
  67. ZUR D, Iglicki M, Busch C, Invernizzi A, et al
    Optical Coherence Tomography Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
    Ophthalmology. 2017 Sep 18. pii: S0161-6420(17)32014.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: